1Kumar P, Wang JM, Bernabeu C. CD105 and angiogenesis. J Pathol, 1996,178: 363-366.
2Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl J Med, 1991,324:1-8.
3Tanaka F, Otake Y, Yanagihara K,et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 anti body and anti-CD105 antibody. Clin Cancer Res, 2001, 7: 3410-3415.
6Rosa AR, Sehirmer CC, Gurski RR, et al. Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophfactor. Diseases of the Esophagus, 2007, 16(2) : 112-118.
7Han U, Can OI, Han S, et al. Expressions of p53, VEGF C, p21 : could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma? Diseases of the Esophagus, 2007, 20(5) : 379-385.
8Boxer GM, Tsiompanou E, Levine T, et al. expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative eoloreetal cancer. Turnout Biol, 2005,26(1) : 1-8.
9Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hypermeability and angiogenesis. Am J Pathol, 1995, 146(5) :1029-1039.
10Tanaka F,Otake Y,Yanagihara K,et al.Evaluation of angiogensis in non-small cell lung cancer:comparison betwenn their CD34 antibody and their CD105 antibody[J].Clin Cancer Res,2001,7:3410-3415.
